Appeals Court Dismisses Amgen’s Epogen Biosimilar Appeal

Drug Industry Daily
A A
An appeals court dismissed Amgen’s appeal of a Delaware district court decision over Hospira’s Epogen biosimilar.

To View This Article:

Login

Subscribe To Drug Industry Daily